This Continuing Education activity is supported by an educational grant from Sandoz Inc.
Jeffrey D. Dunn, PharmD, MBA
Advertisement
Articles by Jeffrey D. Dunn, PharmD, MBA
Patients, payers, providers, and employers are affected by misdiagnosis, undertreatment, and inappropriate management of migraine.
Advertisement
Latest Updated Articles
Leveraging Patient Care Services to Optimize Patient Care in RA: A Pharmacist’s OpportunityPublished: June 15th 2017 | Updated:
- Concepts in Acute Migraine Management: Clinical and Managed Care Perspectives
Published: October 17th 2012 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Five-Year NATALEE Data Show Ribociclib Improves Outcomes in High-Risk HR+/HER2– Early Breast Cancer
2
Abemaciclib Provides Long-Term Survival Benefit in High-Risk Early Breast Cancer
3
Operationalizing Epcoritamab-GemOx in Practice: A Focus on EPCORE NHL-2
4
Durvalumab Plus Chemotherapy Sets New Standard in Resectable Gastric and GEJ Cancer
5
